Treatment Choices for Hepatitis C in Patients with Kidney Disease
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - 13(2018), 5 vom: 07. Mai, Seite 793-795 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fabrizi, Fabrizio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antiviral Agents |
|---|
| Anmerkungen: |
Date Completed 13.11.2019 Date Revised 15.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2215/CJN.12621117 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM281802270 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281802270 | ||
| 003 | DE-627 | ||
| 005 | 20231225032454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.12621117 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0939.xml |
| 035 | |a (DE-627)NLM281802270 | ||
| 035 | |a (NLM)29523677 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fabrizi, Fabrizio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment Choices for Hepatitis C in Patients with Kidney Disease |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2019 | ||
| 500 | |a Date Revised 15.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Developed Countries | |
| 650 | 4 | |a Fluid Therapy | |
| 650 | 4 | |a Hepacivirus | |
| 650 | 4 | |a Hepatitis C | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Kidney Diseases | |
| 650 | 4 | |a Patient Selection | |
| 650 | 4 | |a Prevalence | |
| 650 | 4 | |a kidney disease | |
| 650 | 4 | |a renal dialysis | |
| 650 | 4 | |a therapy | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Messa, Piergiorgio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g 13(2018), 5 vom: 07. Mai, Seite 793-795 |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2018 |g number:5 |g day:07 |g month:05 |g pages:793-795 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.12621117 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2018 |e 5 |b 07 |c 05 |h 793-795 | ||